Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2
2(100.0%)
2Total
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT05903027Recruiting

Gepant treAtments: EffectIveNess and tolERability (GAINER)

Role: collaborator

NCT05903040Completed

Ditan Acute tReatments: Effectiveness and Tolerability (DART)

Role: collaborator

NCT05448092Unknown

Registry for Evaluation of Lumbar Arthrodesis Sagittal alignmEnt

Role: collaborator

NCT05714215Unknown

SECONDs' Italian Translation and Transcultural Validation

Role: collaborator

NCT04224441Phase 2Unknown

Repurposing Chlorpromazine in the Treatment of Glioblastoma

Role: collaborator

NCT02964728Phase 2Completed

Botulinum Toxin in Burning Mouth Syndrome

Role: collaborator

NCT02979145Unknown

Charcot-Marie-Tooth Disease (CMT) Infant Scale (INC-6611)

Role: collaborator

NCT02001038Completed

Survey of Current Management of Orthopaedic Complications in CMT Patients

Role: collaborator

All 8 trials loaded